Related Experiment Video

Updated: Nov 18, 2025

Direct Gene Knock-out of Axolotl Spinal Cord Neural Stem Cells via Electroporation of CAS9 Protein-gRNA Complexes
09:10

Direct Gene Knock-out of Axolotl Spinal Cord Neural Stem Cells via Electroporation of CAS9 Protein-gRNA Complexes

Published on: July 9, 2019

8.2K

Therapeutic potential of SOX2 inhibition for embryonal carcinoma

Hiroshi Ushida1, Tokuhiro Chano, Kahori Minami

  • 1Department of Urology, Shiga University of Medical Science, Shiga, Japan.

The Journal of Urology
|March 20, 2012
PubMed
Abstract

Insights

Targeting SOX2 offers a new therapy for embryonal carcinoma, a type of nonseminomatous germ cell tumor. SOX2 silencing effectively reduced tumor growth in preclinical models, showing therapeutic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Nonseminomatous germ cell tumors (NSGCTs) present challenges due to chemotherapy resistance.
  • Embryonal carcinoma (EC) cells are critical targets for managing NSGCTs.

Purpose of the Study:

  • To investigate SOX2 as a therapeutic target in embryonal carcinoma.
  • To establish a SOX2-targeting therapy approach for EC.

Main Methods:

  • SOX2 expression analysis in human testicular germ cell tumor samples.
  • In vitro and in vivo evaluation of SOX2 knockdown using siRNA in an EC model.

Main Results:

  • SOX2 was specifically expressed in EC foci within tumors, absent in seminoma and yolk sac tumors.
  • SOX2-siRNA induced significant apoptotic cell death in vitro.
  • SOX2 knockdown demonstrated substantial tumor growth suppression in vivo.

Conclusions:

  • SOX2 silencing presents a promising therapeutic strategy for embryonal carcinoma.
  • Further research is required to optimize SOX2-siRNA delivery for clinical application.

More Related Videos

An Optimized Protocol for Electrophoretic Mobility Shift Assay Using Infrared Fluorescent Dye-labeled Oligonucleotides09:58

An Optimized Protocol for Electrophoretic Mobility Shift Assay Using Infrared Fluorescent Dye-labeled Oligonucleotides

Published on: November 29, 2016

16.3K
Blastomere Explants to Test for Cell Fate Commitment During Embryonic Development14:08

Blastomere Explants to Test for Cell Fate Commitment During Embryonic Development

Published on: January 26, 2013

15.6K

Related Concept Videos

Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
42.1K
Inheritance of Chromatin Structures03:17

Inheritance of Chromatin Structures

Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
6.9K
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.2K
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
30.0K